Do analysts recommend AIMDW or NTHI?

Neonc Technologies has a consensus target price of $16.00, indicating a potential upside of 366.47%. Given Neonc Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Neonc Technologies is more favorable than Ainos. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ainos 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Neonc Technologies 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has better valuation & earnings, AIMDW or NTHI?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ainos $18.11K N/A N/A N/A N/A Neonc Technologies N/A N/A N/A N/A N/A

Is AIMDW or NTHI more profitable?

Company Net Margins Return on Equity Return on Assets Ainos N/A N/A N/A Neonc Technologies N/A N/A N/A

Do analysts rate NTHI or ALVOW?

Neonc Technologies presently has a consensus price target of $16.00, suggesting a potential upside of 366.47%. Given Neonc Technologies' stronger consensus rating and higher probable upside, equities research analysts clearly believe Neonc Technologies is more favorable than Alvotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neonc Technologies 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Alvotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better valuation & earnings, NTHI or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Neonc Technologies N/A N/A N/A N/A N/A Alvotech $559.42M N/A N/A N/A N/A

Is NTHI or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets Neonc Technologies N/A N/A N/A Alvotech N/A N/A N/A

Do analysts prefer NTHI or ACABW?

Neonc Technologies presently has a consensus price target of $16.00, suggesting a potential upside of 366.47%. Given Neonc Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Neonc Technologies is more favorable than Atlantic Coastal Acquisition Corp. II. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neonc Technologies 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Atlantic Coastal Acquisition Corp. II 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better valuation and earnings, NTHI or ACABW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Neonc Technologies N/A N/A N/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A N/A N/A

Is NTHI or ACABW more profitable?

Company Net Margins Return on Equity Return on Assets Neonc Technologies N/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A

Do analysts rate NTHI or BFRIW?

Neonc Technologies currently has a consensus target price of $16.00, suggesting a potential upside of 366.47%. Given Neonc Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe Neonc Technologies is more favorable than Biofrontera. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neonc Technologies 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Biofrontera 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings and valuation, NTHI or BFRIW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Neonc Technologies N/A N/A N/A N/A N/A Biofrontera $43.20M N/A N/A N/A N/A

Is NTHI or BFRIW more profitable?

Company Net Margins Return on Equity Return on Assets Neonc Technologies N/A N/A N/A Biofrontera N/A N/A N/A

Do analysts recommend NTHI or CALA?

Neonc Technologies currently has a consensus price target of $16.00, suggesting a potential upside of 366.47%. Given Neonc Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Neonc Technologies is more favorable than Calithera Biosciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neonc Technologies 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Calithera Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable earnings and valuation, NTHI or CALA?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Neonc Technologies N/A N/A N/A N/A N/A Calithera Biosciences N/A N/A -$39.65M N/A N/A

Is NTHI or CALA more profitable?

Company Net Margins Return on Equity Return on Assets Neonc Technologies N/A N/A N/A Calithera Biosciences N/A N/A N/A

Neonc Technologies (NTHI) Competitors

$3.43 -0.20 (-5.51%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$3.46 +0.03 (+0.87%)

As of 07/24/2026 05:36 PM Eastern

Compare

NTHI vs. AIMDW, ALVOW, ACABW, BFRIW, and CALA

Should you buy Neonc Technologies stock or one of its competitors? MarketBeat compares Neonc Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Neonc Technologies include Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry.

How does Neonc Technologies compare to Ainos?

Ainos (NASDAQ:AIMDW) and Neonc Technologies (NASDAQ:NTHI) are both pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment and analyst recommendations.

In the previous week, Ainos and Ainos both had 1 articles in the media. Ainos' average media sentiment score of 1.87 equaled Neonc Technologies'average media sentiment score.

Company	Overall Sentiment
Ainos	Very Positive
Neonc Technologies	Very Positive

Company	Net Margins	Return on Equity	Return on Assets
Ainos	N/A	N/A	N/A
Neonc Technologies	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ainos	$18.11K	N/A	N/A	N/A	N/A
Neonc Technologies	N/A	N/A	N/A	N/A	N/A

Neonc Technologies has a consensus target price of $16.00, indicating a potential upside of 366.47%. Given Neonc Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Neonc Technologies is more favorable than Ainos.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ainos	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Neonc Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Neonc Technologies beats Ainos on 3 of the 4 factors compared between the two stocks.

How does Neonc Technologies compare to Alvotech?

Neonc Technologies (NASDAQ:NTHI) and Alvotech (NASDAQ:ALVOW) are both pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, media sentiment, institutional ownership, dividends and earnings.

Neonc Technologies presently has a consensus price target of $16.00, suggesting a potential upside of 366.47%. Given Neonc Technologies' stronger consensus rating and higher probable upside, equities research analysts clearly believe Neonc Technologies is more favorable than Alvotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neonc Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Alvotech	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Neonc Technologies and Neonc Technologies both had 1 articles in the media. Neonc Technologies' average media sentiment score of 1.87 beat Alvotech's score of 0.93 indicating that Neonc Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Neonc Technologies	Very Positive
Alvotech	Positive

Company	Net Margins	Return on Equity	Return on Assets
Neonc Technologies	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neonc Technologies	N/A	N/A	N/A	N/A	N/A
Alvotech	$559.42M	N/A	N/A	N/A	N/A

Summary

Neonc Technologies beats Alvotech on 4 of the 5 factors compared between the two stocks.

How does Neonc Technologies compare to Atlantic Coastal Acquisition Corp. II?

Neonc Technologies (NASDAQ:NTHI) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

Company	Net Margins	Return on Equity	Return on Assets
Neonc Technologies	N/A	N/A	N/A
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A

Neonc Technologies presently has a consensus price target of $16.00, suggesting a potential upside of 366.47%. Given Neonc Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Neonc Technologies is more favorable than Atlantic Coastal Acquisition Corp. II.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neonc Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Atlantic Coastal Acquisition Corp. II	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neonc Technologies	N/A	N/A	N/A	N/A	N/A
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A

In the previous week, Neonc Technologies had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Neonc Technologies and 0 mentions for Atlantic Coastal Acquisition Corp. II. Neonc Technologies' average media sentiment score of 1.87 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Neonc Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Neonc Technologies	Very Positive
Atlantic Coastal Acquisition Corp. II	Neutral

Summary

Neonc Technologies beats Atlantic Coastal Acquisition Corp. II on 5 of the 5 factors compared between the two stocks.

How does Neonc Technologies compare to Biofrontera?

Neonc Technologies (NASDAQ:NTHI) and Biofrontera (NASDAQ:BFRIW) are both pharmaceutical products companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment.

Neonc Technologies currently has a consensus target price of $16.00, suggesting a potential upside of 366.47%. Given Neonc Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe Neonc Technologies is more favorable than Biofrontera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neonc Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Biofrontera	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Neonc Technologies and Neonc Technologies both had 1 articles in the media. Neonc Technologies' average media sentiment score of 1.87 equaled Biofrontera'saverage media sentiment score.

Company	Overall Sentiment
Neonc Technologies	Very Positive
Biofrontera	Very Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neonc Technologies	N/A	N/A	N/A	N/A	N/A
Biofrontera	$43.20M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Neonc Technologies	N/A	N/A	N/A
Biofrontera	N/A	N/A	N/A

Summary

Neonc Technologies beats Biofrontera on 3 of the 4 factors compared between the two stocks.

How does Neonc Technologies compare to Calithera Biosciences?

Neonc Technologies (NASDAQ:NTHI) and Calithera Biosciences (NASDAQ:CALA) are both pharmaceutical preparations industry companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neonc Technologies	N/A	N/A	N/A	N/A	N/A
Calithera Biosciences	N/A	N/A	-$39.65M	N/A	N/A

In the previous week, Neonc Technologies had 1 more articles in the media than Calithera Biosciences. MarketBeat recorded 1 mentions for Neonc Technologies and 0 mentions for Calithera Biosciences. Neonc Technologies' average media sentiment score of 1.87 beat Calithera Biosciences' score of 0.00 indicating that Neonc Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Neonc Technologies	Very Positive
Calithera Biosciences	Neutral

Neonc Technologies currently has a consensus price target of $16.00, suggesting a potential upside of 366.47%. Given Neonc Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Neonc Technologies is more favorable than Calithera Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neonc Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Calithera Biosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Net Margins	Return on Equity	Return on Assets
Neonc Technologies	N/A	N/A	N/A
Calithera Biosciences	N/A	N/A	N/A

Summary

Neonc Technologies beats Calithera Biosciences on 5 of the 5 factors compared between the two stocks.

Get Neonc Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NTHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NTHI vs. The Competition

Export

Metric	Neonc Technologies	Pharmaceutical Preparations Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	N/A	$975.85M	$7.24B	$12.26B
Dividend Yield	N/A	4.84%	40.99%	9.79%
P/E Ratio	N/A	1.53	23.62	23.64
Price / Sales	N/A	104.46	132.14	89.50
Price / Cash	N/A	20.06	165.01	59.64
Price / Book	N/A	8.47	12.77	6.07
Net Income	N/A	-$2.70M	$120.21M	$331.99M
7 Day Performance	-0.87%	-2.29%	-0.98%	-0.63%
1 Month Performance	-23.95%	-3.97%	-2.00%	-2.00%
1 Year Performance	-32.75%	27.39%	9.75%	13.62%

Neonc Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NTHI Neonc Technologies	3.7666 of 5 stars	$3.43 -5.5%	$16.00 +366.5%	-27.0%	$0.00	N/A	N/A	8	Positive News
AIMDW Ainos	N/A	$0.11 +18.9%	N/A	-25.9%	$0.00	$18.11K	N/A	40	Positive News
ALVOW Alvotech	N/A	$0.17 flat	N/A	-92.3%	$0.00	$559.42M	N/A	4	Positive News
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.00 flat	N/A	N/A	$0.00	N/A	N/A	15
BFRIW Biofrontera	N/A	$0.03 flat	N/A	N/A	$0.00	$43.20M	N/A	70	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NTHI) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Neonc Technologies (NTHI) Competitors

NTHI vs. AIMDW, ALVOW, ACABW, BFRIW, and CALA

How does Neonc Technologies compare to Ainos?

Summary

How does Neonc Technologies compare to Alvotech?

Summary

How does Neonc Technologies compare to Atlantic Coastal Acquisition Corp. II?

Summary

How does Neonc Technologies compare to Biofrontera?

Summary

How does Neonc Technologies compare to Calithera Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTHI vs. The Competition

Neonc Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Neonc Technologies (NTHI) Competitors

NTHI vs. AIMDW, ALVOW, ACABW, BFRIW, and CALA

How does Neonc Technologies compare to Ainos?

Does the media favor AIMDW or NTHI?

Is AIMDW or NTHI more profitable?

Which has better valuation & earnings, AIMDW or NTHI?

Do analysts recommend AIMDW or NTHI?

Summary

How does Neonc Technologies compare to Alvotech?

Do analysts rate NTHI or ALVOW?

Does the media refer more to NTHI or ALVOW?

Is NTHI or ALVOW more profitable?

Which has better valuation & earnings, NTHI or ALVOW?

Summary

How does Neonc Technologies compare to Atlantic Coastal Acquisition Corp. II?

Is NTHI or ACABW more profitable?

Do analysts prefer NTHI or ACABW?

Which has better valuation and earnings, NTHI or ACABW?

Does the media refer more to NTHI or ACABW?

Summary

How does Neonc Technologies compare to Biofrontera?

Do analysts rate NTHI or BFRIW?

Does the media refer more to NTHI or BFRIW?

Which has stronger earnings and valuation, NTHI or BFRIW?

Is NTHI or BFRIW more profitable?

Summary

How does Neonc Technologies compare to Calithera Biosciences?

Which has preferable earnings and valuation, NTHI or CALA?

Does the media refer more to NTHI or CALA?

Do analysts recommend NTHI or CALA?

Is NTHI or CALA more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTHI vs. The Competition

Neonc Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools